Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Achilles raises £100mm in Series B round

Executive Summary

Achilles Therapeutics Ltd. (cancer immunotherapies) raised £100mm ($121mm) in its Series B round. RA Capital led and was joined by founding investor Syncona and first-time buyers Forbion, Invus, Perceptive Advisors, and Redmile Group. Funds will support two human proof-of-concept studies with a personalized T-cell therapy targeting clonal neoantigens for melanoma and non-small cell lung cancer.
Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Pharmacogenetics-Pharmacogenomics
    • Drug Discovery Tools
      • Bioinformatics
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies

UsernamePublicRestriction

Register